Galecto Cash Over Time
| GLTO Stock | USD 4.05 0.08 2.02% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Galecto Performance and Galecto Correlation. Galecto |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galecto. If investors know Galecto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galecto listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galecto's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash Analysis
Compare Galecto and related stocks such as Terns Pharmaceuticals, Day One Biopharmaceu, and Acumen Pharmaceuticals Cash Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TERN | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 12.3 M | 74.9 M | 47.7 M | 143.2 M | 79.9 M | 91.9 M | 80.8 M |
| DAWN | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 43.7 M | 284.3 M | 85.3 M | 230.8 M | 125 M | 146 M |
| ABOS | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 43.8 M | 122.2 M | 130.1 M | 66.9 M | 76.9 M | 81.3 M |
| MLTX | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 8 M | 39.5 M | 451.2 M | 180.4 M | 149.7 M |
| MOLN | 96.1 M | 96.1 M | 96.1 M | 96.1 M | 188.4 M | 195.4 M | 149.7 M | 131.3 M | 99 M | 75.7 M | 133.7 M | 71.8 M | 87.9 M | 67.3 M | 63.9 M | 90.7 M |
| CNTA | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 7.2 M | 595.1 M | 393.6 M | 128 M | 147.2 M | 139.9 M |
| EWTX | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 104.9 M | 280.8 M | 351.9 M | 86.1 M | 41.7 M | 39.6 M |
| LYEL | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 140.4 M | 293.8 M | 123.6 M | 145.6 M | 105.6 M | 120.8 M |
| CGEM | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.2 K | 118 | 91.0 | 33.8 M | 33.8 M | 63.2 M | 168.2 M | 430.9 M | 550.1 M | 98.4 M | 83 M | 142.8 M |
| GLUE | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 41.7 M | 346.1 M | 54.9 M | 128.1 M | 147.3 M | 126.9 M |
| RVMD | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 69.6 M | 16.7 M | 104.3 M | 108.5 M | 161.4 M | 696.1 M | 543.1 M | 570.2 M |
| ACRV | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 99.6 M | 29.5 M | 36 M | 41.4 M | 45.8 M |
| AADI | 7.5 K | 4.1 K | 4.6 K | 6.3 K | 5.3 K | 5.1 M | 1.6 M | 20.3 M | 62.6 M | 38.5 M | 4.5 M | 149 M | 39 M | 62.9 M | 72.3 M | 75.9 M |
| ALGS | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 69.6 M | 220.4 M | 186.8 M | 81.3 M | 135.7 M | 37 M | 35.1 M |
| SPRO | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 10.3 M | 87.3 M | 34.1 M | 29.7 M | 85.2 M | 112.6 M | 109.1 M | 76.3 M | 87.8 M | 67.3 M |
| BOLT | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 34.8 M | 5.5 M | 27.4 M | 9.2 M | 10.8 M | 9.7 M | 13.5 M |
| CHRS | 14.5 M | 14.5 M | 14.5 M | 39.6 M | 150.4 M | 158.2 M | 124.9 M | 126.9 M | 72.4 M | 177.7 M | 541.2 M | 417.2 M | 63.5 M | 102.9 M | 118.3 M | 182.4 M |
Galecto and related stocks such as Terns Pharmaceuticals, Day One Biopharmaceu, and Acumen Pharmaceuticals Cash description
Cash refers to the most liquid asset of Galecto, which is listed under current asset account on Galecto balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Galecto customers. The amounts must be unrestricted with restricted cash listed in a different Galecto account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.My Equities
My Current Equities and Potential Positions
| Galecto | GLTO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 4.05
Check out Galecto Performance and Galecto Correlation. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Galecto technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.